139 related articles for article (PubMed ID: 37066234)
21. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity.
Vidyarthi A; Agnihotri T; Khan N; Singh S; Tewari MK; Radotra BD; Chatterjee D; Agrewala JN
Cancer Immunol Immunother; 2019 Dec; 68(12):1995-2004. PubMed ID: 31690954
[TBL] [Abstract][Full Text] [Related]
22. Immune microenvironment of gliomas.
Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
[TBL] [Abstract][Full Text] [Related]
23. TREM2 expression on the microglia resolved lead exposure-induced neuroinflammation by promoting anti-inflammatory activities.
Su P; Zhang J; Wu J; Chen H; Luo W; Hu M
Ecotoxicol Environ Saf; 2023 Jul; 260():115058. PubMed ID: 37245276
[TBL] [Abstract][Full Text] [Related]
24. TREM2 Promotes Immune Evasion by Mycobacterium tuberculosis in Human Macrophages.
Dabla A; Liang YC; Rajabalee N; Irwin C; Moonen CGJ; Willis JV; Berton S; Sun J
mBio; 2022 Aug; 13(4):e0145622. PubMed ID: 35924849
[TBL] [Abstract][Full Text] [Related]
25. Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.
Raha-Chowdhury R; Henderson JW; Raha AA; Stott SRW; Vuono R; Foscarin S; Wilson L; Annus T; Fincham R; Allinson K; Devalia V; Friedland RP; Holland A; Zaman SH
J Alzheimers Dis; 2018; 61(3):1143-1162. PubMed ID: 29278889
[TBL] [Abstract][Full Text] [Related]
26. Exploring the Impact of TREM2 in Tumor-Associated Macrophages.
Khantakova D; Brioschi S; Molgora M
Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746551
[TBL] [Abstract][Full Text] [Related]
27. TREM2 regulates microglial phagocytosis of synapses in innate immune tolerance.
Meng J; Han L; Xu H; Zhang L; Liu Z; Zhou Y; Zhang X; Luo H; Zhang YW
Int Immunopharmacol; 2024 Jan; 127():111445. PubMed ID: 38147777
[TBL] [Abstract][Full Text] [Related]
28. A reporter cell system for the triggering receptor expressed on myeloid cells 2 reveals differential effects of disease-associated variants on receptor signaling and activation by antibodies against the stalk region.
Ibach M; Mathews M; Linnartz-Gerlach B; Theil S; Kumar S; Feederle R; Brüstle O; Neumann H; Walter J
Glia; 2021 May; 69(5):1126-1139. PubMed ID: 33314333
[TBL] [Abstract][Full Text] [Related]
29. TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson's disease.
Zhang Y; Feng S; Nie K; Li Y; Gao Y; Gan R; Wang L; Li B; Sun X; Wang L; Zhang Y
Biochem Biophys Res Commun; 2018 May; 499(4):797-802. PubMed ID: 29621548
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of TREM2 enhances glioma cell proliferation and invasion: a therapeutic target in human glioma.
Wang XQ; Tao BB; Li B; Wang XH; Zhang WC; Wan L; Hua XM; Li ST
Oncotarget; 2016 Jan; 7(3):2354-66. PubMed ID: 26506595
[TBL] [Abstract][Full Text] [Related]
31. Triggering receptor expressed on myeloid cells 2 deficiency exacerbates injury-induced inflammation in a mouse model of tauopathy.
Katsumoto A; Kokiko-Cochran ON; Bemiller SM; Xu G; Ransohoff RM; Lamb BT
Front Immunol; 2022; 13():978423. PubMed ID: 36389767
[TBL] [Abstract][Full Text] [Related]
32. Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke.
Sieber MW; Jaenisch N; Brehm M; Guenther M; Linnartz-Gerlach B; Neumann H; Witte OW; Frahm C
PLoS One; 2013; 8(1):e52982. PubMed ID: 23301011
[TBL] [Abstract][Full Text] [Related]
33. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
[TBL] [Abstract][Full Text] [Related]
34. Soluble Trem2 is a negative regulator of erythrophagocytosis after intracerebral hemorrhage in a CD36 receptor recycling manner.
Zhou H; Li J; Hu L; Yu J; Fu X; Liang F; Yan F; Chen G
J Adv Res; 2023 Feb; 44():185-199. PubMed ID: 36725189
[TBL] [Abstract][Full Text] [Related]
35. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.
Li H; Miao Y; Zhong L; Feng S; Xu Y; Tang L; Wu C; Zhang X; Gu L; Diao H; Wang H; Wen Z; Yang M
Front Immunol; 2023; 14():1162032. PubMed ID: 37187751
[TBL] [Abstract][Full Text] [Related]
36. High-salt diet downregulates TREM2 expression and blunts efferocytosis of macrophages after acute ischemic stroke.
Hu M; Lin Y; Men X; Wang S; Sun X; Zhu Q; Lu D; Liu S; Zhang B; Cai W; Lu Z
J Neuroinflammation; 2021 Apr; 18(1):90. PubMed ID: 33845849
[TBL] [Abstract][Full Text] [Related]
37. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
[TBL] [Abstract][Full Text] [Related]
38. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant
Cheng Q; Danao J; Talreja S; Wen P; Yin J; Sun N; Li CM; Chui D; Tran D; Koirala S; Chen H; Foltz IN; Wang S; Sambashivan S
J Biol Chem; 2018 Aug; 293(32):12620-12633. PubMed ID: 29599291
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2).
Atagi Y; Liu CC; Painter MM; Chen XF; Verbeeck C; Zheng H; Li X; Rademakers R; Kang SS; Xu H; Younkin S; Das P; Fryer JD; Bu G
J Biol Chem; 2015 Oct; 290(43):26043-50. PubMed ID: 26374899
[TBL] [Abstract][Full Text] [Related]
40. Myeloid LXR (Liver X Receptor) Deficiency Induces Inflammatory Gene Expression in Foamy Macrophages and Accelerates Atherosclerosis.
Endo-Umeda K; Kim E; Thomas DG; Liu W; Dou H; Yalcinkaya M; Abramowicz S; Xiao T; Antonson P; Gustafsson JÅ; Makishima M; Reilly MP; Wang N; Tall AR
Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):719-731. PubMed ID: 35477277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
